← Leaderboards
Mara Lorenzi
Schepens Eye Research Institute
$4,174,356
Attributed
$5,209,387
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $665.7K · FY2009–15$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$5,209,387 · 4
By mechanism
R01$4,672,562 · 3
R21$536,825 · 1
Top collaborators
- Chiara Gerhardinger5 shared
Most similar at Schepens Eye Research Institute
Same institution · by research overlap
- Ann E Elsner$9,473,451
- Chiara Gerhardinger$2,743,460
Others in their field
Top investigators on “Diabetic Retinopathy”
- John M Lachin · George Washington University$140,240,809
- David M Nathan · Massachusetts Institute Of Technology$123,291,647
- Rose A Gubitosi-Klug · Case Western Reserve University$71,942,336
- Rohit Varma · University Of Southern California$56,244,772
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Adam R Glassman · Jaeb Center For Health Research, Inc.$50,075,374
Research focus
Diabetic RetinopathyRetinaDiabetes MellitusApoptosisAspirinHyperglycemiaRetinalReceptorRetinal DiseasesInflammationPathologyPericytesGrowth FactorRetina Blood Vessel StructureInterestBlood CapillariesDiabeticComplications Of Diabetes MellitusCapillaryExperimental Diabetes MellitusBlood VesselsEndothelial CellsLeadSignal Transduction
Grant awards (13)
Protection and Repair of Retinal Microvessels$241,325
R21 · FY2015 · EY · contact PI
Protection and Repair of Retinal Microvessels$295,500
R21 · FY2014 · EY · contact PI
Mechanisms of action of drugs that prevent experimental diabetic retinopathy$460,944
R01 · FY2012 · EY · contact PI
Mechanisms of action of drugs that prevent experimental diabetic retinopathy$462,132
R01 · FY2011 · EY · contact PI
Mechanisms of action of drugs that prevent experimental diabetic retinopathy$483,863
R01 · FY2010 · EY · contact PI
Mechanisms of action of drugs that prevent experimental diabetic retinopathy$181,873
R01 · FY2010 · EY · contact PI
Mechanisms of action of drugs that prevent experimental diabetic retinopathy$481,250
R01 · FY2009 · EY · contact PI
Retinal Blood Flow and Microthrombi in Type 1 Diabetes$465,000
R01 · FY2004 · EY
Retinal Blood Flow and Microthrombi in Type 1 Diabetes$465,000
R01 · FY2003 · EY
Retinal Blood Flow and Microthrombi in Type 1 Diabetes$465,000
R01 · FY2002 · EY
HIGH GLUCOSE, DNA, AND DIABETIC COMPLICATIONS$435,000
R01 · FY2002 · EY
HIGH GLUCOSE, DNA, AND DIABETIC COMPLICATIONS$408,000
R01 · FY2001 · EY
HIGH GLUCOSE, DNA, AND DIABETIC COMPLICATIONS$364,500
R01 · FY2000 · EY